Sign in →

Test Code LAB21 Carbamazepine (Tegretol)

Useful For

Used in monitoring Carbamazepine drug levels, a drug used in the treatment of trigeminal neuralgia, all forms of partial epilepsy, generalized tonic-clonic seizures, and simple/complex partial seizures.

Methodology

Kinetic interaction of microparticles (KIMS)

Performing Laboratory

Bozeman Health Laboratory Services

Specimen Requirements

Specimen Type: Plasma or serum
Container/Tube: Light-green top (lithium heparin gel), red top, or gold top
Specimen Volume: 1 mL
Specimen Minimum Volume: 0.5 mL

Collection Instructions:

1. Spin down within 2 hours of draw and remove plasma or serum from cells.

2. Label specimen as plasma or serum.

Specimen Transport Temperature

Ambient/Refrigerated

Specimen Stability

Specimen Type Temperature Time
Plasma or Serum Ambient 2 days
  Refrigerated 7 days
  Frozen 1 month

Reference Values

Therapeutic concentration: 4.0-12.0 µg/mL

Critical value concentration (automatic call-back): >15.0 µg/mL

 

Therapeutic carbamazepine concentrations vary significantly depending on the individual patient and on the use of other drugs with carbamazepine.

A therapeutic range of 4.0 to 12.0 µg/mL (16.9-50.8 µmol/L) includes effective serum/plasma concentrations for many patients, however, some individuals are best treated at concentrations outside this range.

A therapeutic range of 8.0 to 12.0 µg/mL (33.9-50.8 µmol/L) for peak drug levels indicates effective plasma or serum levels for many patients who are on carbamazepine alone.

Patients who are taking carbamazepine in conjunction with other anti-epileptic drugs have a recommended therapeutic range of 4.0 to 8.0 µg/mL (16.9-33.9 µmol/L). However, some individuals are best treated at concentrations outside this range.

Concentrations >15.0 µg/mL (63.5 µmol/L) are often associated with toxic symptoms. The physician must determine the most appropriate therapeutic range for each patient.

Day(s) Test Set Up

Monday through Sunday

Test Classification and CPT Coding

80156